| Schedule of Segment Reporting Provided to the CODM |
Segment reporting for the three and six months ended June 30, 2025 and 2024 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Product revenue, net |
|
$ |
12,800 |
|
|
$ |
— |
|
|
$ |
20,563 |
|
|
$ |
— |
|
Revenue under collaboration agreements |
|
|
2,594 |
|
|
|
500 |
|
|
|
2,804 |
|
|
|
500 |
|
Revenue under supply agreements |
|
|
323 |
|
|
|
— |
|
|
|
323 |
|
|
|
— |
|
Total revenue |
|
|
15,717 |
|
|
|
500 |
|
|
|
23,690 |
|
|
|
500 |
|
Segment operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold |
|
|
4,984 |
|
|
|
— |
|
|
|
6,078 |
|
|
|
— |
|
Clinical |
|
|
1,250 |
|
|
|
1,226 |
|
|
|
2,454 |
|
|
|
4,042 |
|
Development |
|
|
2,151 |
|
|
|
2,591 |
|
|
|
3,252 |
|
|
|
4,099 |
|
Medical affairs |
|
|
1,073 |
|
|
|
421 |
|
|
|
2,018 |
|
|
|
754 |
|
Sales and marketing |
|
|
40,925 |
|
|
|
2,694 |
|
|
|
67,682 |
|
|
|
4,145 |
|
General and administrative |
|
|
7,118 |
|
|
|
5,505 |
|
|
|
15,837 |
|
|
|
9,195 |
|
Stock-based compensation |
|
|
5,371 |
|
|
|
3,365 |
|
|
|
10,669 |
|
|
|
6,680 |
|
Other |
|
|
459 |
|
|
|
38 |
|
|
|
491 |
|
|
|
117 |
|
Total segment operating expenses |
|
|
63,331 |
|
|
|
15,840 |
|
|
|
108,481 |
|
|
|
29,032 |
|
Loss from operations |
|
|
(47,614 |
) |
|
|
(15,340 |
) |
|
|
(84,791 |
) |
|
|
(28,532 |
) |
Other income, net |
|
|
2,731 |
|
|
|
2,824 |
|
|
|
5,968 |
|
|
|
5,724 |
|
Net loss |
|
$ |
(44,883 |
) |
|
$ |
(12,516 |
) |
|
$ |
(78,823 |
) |
|
$ |
(22,808 |
) |
|